Collaborations and Licenses
Our expertise in the design and manufacture of RNAi oligonucleotides, coupled with our SirFinder™ software, positions SYLENTIS as a secure partner for pharmaceutical or biopharmaceutical companies looking to access the benefits of siRNAs and the next generation of revolutionary molecules.
As the backbone of our business, we explore new opportunities in very diverse fields of knowledge where RNAi can provide a value proposition, with different models of collaboration, as well as strengthening existing links with academia and industrial partners.
The Sylentis team actively seeks global and local co-operation opportunities with other industry players. These opportunities may include a wide range of arrangements, such as co-development, out-licensing, consortia and academic partnerships.
We have proven experience collaborating with (bio)pharmaceutical and biotech companies, as well as researchers and key opinion leaders around the world. This strengthens our relationships with different partners in the industry, facilitating long-term collaborations.
Contact us at email@example.com